 Comparison fructosamine detection diabetes mellitus use serum AG levels diabetes mellitus sensitivity specificity fructosamine FA AG subjects institutions Japan individuals diet and/or drug therapy diabetes Subjects groups World Health Organization criteria nondiabetic control subjects subjects impaired glucose tolerance IGT patients diabetes patients disorders IGT overlap AG values group FA values AG levels plasma glucose FA levels micrograms/ml normal limit AG level specific decreased AG level diabetes mellitus sensitivity selectivity index sensitivity value times specificity value AG determinations superior FA measurements diabetes combinations tests AG AG Thus advantages AG wide variance fair glycemic control negligible influence sampling conditions AG level potential FA level screening criterion diabetes